| Literature DB >> 33199843 |
Ascensión Vicente1, Luis-Alberto Bravo-González1, Ana López-Romero1, Clara Serna Muñoz2, Julio Sánchez-Meca3.
Abstract
The aim of this study was to evaluate the craniofacial cephalometric characteristics of individuals with Down syndrome (DS), comparing them with healthy subjects. An electronic search was made in Pubmed, Embase, Lilacs, Scopus, Medline and Web of Science without imposing limitations on publication date or language. Studies were selecting following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. The PECO acronym was applied as follows: P (population), individuals with DS; E, (exposition) diagnosis of DS; C (comparison), individuals without DS; O (outcomes) craniofacial characteristics based on cephalometric measurements. Independent reviewers performed data extraction and assessed the methodological quality of the articles using the Newcastle-Ottawa Quality-Assessment-scale. Seven case-control studies were included in meta-analysis. Given the variability of the cephalometric measurements used, only those that had been reported in at least three or more works could be included. Anterior cranial base length (SN), posterior cranial base length (SBa), total cranial base length (BaN), effective length of the maxilla (CoA), sagittal relationship between subspinale and supramentale (ANB), anterior facial height (NMe), and posterior facial height (SGo) values were significantly lower in the DS population than among control subjects. No significant differences were found in sagittal position of subspinale relative to cranial base (SNA) and sagittal position of supramentale relative to cranial base (SNB). Summarizing, individuals with DS present a shorter and flatter cranial base than the general population, an upper jaw of reduced sagittal dimension, as well as a tendency toward prognatic profile, with the medium third of the face flattened and a reduced anterior and posterior facial heights.Entities:
Mesh:
Year: 2020 PMID: 33199843 PMCID: PMC7669844 DOI: 10.1038/s41598-020-76984-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow diagram of the search strategy.
Figure 2Cephalometric landmarks (S Sella, N Nasion, Ba Basion, A A point, Co Condilion, B B point, Me Menton, Go Gonion), Cranial base measurements (SN length, SBa length, BaN length, SNBa angle), Maxilar measurements (SNA angle, CoA length), Mandibular measurements (SNB angle), Maxilo-Mandibular relation (ANB angle), Facial heights (NMe length, SGo length).
Angular and linear cephalometric measurements and their definitions.
| Cephalometric measurements | Definitions |
|---|---|
| S-N length, mm | The distance between Sella point and Nasion: anterior cranial base length |
| S-Ba length, mm | The distance between Sella and Basion: posterior cranial base length |
| Ba-N length, mm | The distance between Basion and Nasion: total cranial base length |
| S-N-Ba angle | Posterior cranial base inclination |
| S-N-A angle | Angle between cranial base to subspinale (A-point): sagittal position of subspinale relative to cranial base |
| Co-A, mm | Length of the line drawn from Condilion to A point: effective length of the maxilla |
| S-N-B angle | Angle between cranial base to supramentale (B-point): sagittal position of supramentale relative to cranial base |
| ANB angle | Angle between N-A and N-B: relative position of maxilla and mandible to each other |
| N-Me length, mm | The distance between Nation and Menton: anterior facial height |
| S-Go length, mm | The distance between Sella point and Gonion: posterior facial height |
Methodological quality for all 9 case control studies identified by the search strategy, assessed using the Newcastle–Ottawa-Scale.
| References | Country | Study design | Criteriaa | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selection | Comparability | Exposure | Total score | |||||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |||||
| Tosso and Naval[ | France | Case–control | * | * | * | * | * | * | * | * | 8 | |
| Fischer-Brandies[ | Germany | Case–control | * | * | * | * | * | * | 6 | |||
| Clarkson et al.[ | Colombia | Case–control | * | * | * | * | * | * | * | 7 | ||
| Alió et al.[ | Spain | Case–control | * | * | * | * | * | * | * | * | * | 9 |
| Suri et al.[ | Canada | Case–control | * | * | * | * | * | * | * | * | * | 9 |
| Silva and Valladares-Neto[ | Brazil | Case–control | * | * | * | * | * | * | * | * | 8 | |
| Alió et al.[ | Spain | Case–control | * | * | * | * | * | * | * | * | * | 9 |
| Korayem and Alkofide[ | Saudi Arabia | Case–control | * | * | * | * | * | * | * | * | * | 9 |
| Allareddy et al.[ | USA | Case–control | * | * | * | * | * | * | 6 | |||
a(1) Adequate case definition, (2) Representativeness of the cases, (3) Selection of controls, (4) Definition of controls, (5) Comparability of Cases and Controls on the basis of the design or analysis (age y ethnicity), (6) Ascertainment of exposure, (7) Same method of ascertainment for cases and controls, (8) Non-response rate.
Study characteristics of the 7 case–control studies included in the sistematic review and meta-analyses.
| References | Nos | Partipants | Age range | Ethnicity | Sex | Cephalometric measurements (Mean ± SD) |
|---|---|---|---|---|---|---|
| Alió et al.[ | 9 | Cases: 47 | Cases: 8–18 | Cases: Caucasian | Cases: 22 ♀ 25♂ | SN (mm) |
| Controls: 38 | Controls: 8–18 | Controls: Caucasian | Controls: 16 ♀ 22♂ | Cases: 63.67 ± 4.04 Controls:72.26 ± 2.84 | ||
| SBa(mm) | ||||||
| Cases: 42.33 ± 3.22 Controls: 46.30 ± 3.03 | ||||||
| NBa (mm) | ||||||
| Cases: 100.9 ± 5.55 Controls: 109.6 ± 4.36 | ||||||
| SNBa (°) | ||||||
| Cases: 143.4 ± 4.76 Controls: 133.9 ± 4.12 | ||||||
| Clarkson et al.[ | 7 | Cases: 14 | Cases: 8–11 | Cases: Colombian | Cases: No data | SN (mm) |
| Controls: 14 | Controls: 8–11 | Controls: Colombian | Controls: No data | Cases:63.3 ± 3.48 Controls:69.10: ± 3.48 | ||
| SNA (°) | ||||||
| Cases: 80.5 ± 2.68 Controls: 82.5 ± 2.68 | ||||||
| ANB (°) | ||||||
| Cases:3.3 ± 2.48 Controls: 4.7 ± 2.48 | ||||||
| NMe (mm) | ||||||
| Cases: 103.5 ± 6.99 Controls: 113.2 ± 6.99 | ||||||
| SGo (mm) | ||||||
| Cases:65.7 ± 5.56 Controls:72.9 ± 5.56 | ||||||
| Silva and Valladares-Neto[ | 8 | Cases: 30 | Cases: 6–11 | Cases: Caucasian | Cases: 30♂ | SN (mm) |
| Controls: 30 | Controls: 6–11 | Controls: Caucasian | Controls: 30♂ | Cases: 62.2 ± 3.78 Controls: 69.6 ± 4.22 | ||
| SBa(mm) | ||||||
| Cases: 42.2 ± 3.08 Controls: 44.20 ± 2.84 | ||||||
| NBa (mm) | ||||||
| Cases: 96.6 ± 5.28 Controls: 103.3 ± 5.86 | ||||||
| SNBa (°) | ||||||
| Cases: 134.6 ± 4.9 Controls: 128.1 ± 2.85 | ||||||
| SNA (°) | ||||||
| Cases: 79.9 ± 3.91 Controls: 80.9 ± 3.19 | ||||||
| CoA (mm) | ||||||
| Cases: 75.4 ± 4.56 Controls: 84.8 ± 4.36 | ||||||
| SNB (°) | ||||||
| Cases: 78.4 ± 4.3 Controls: 81 ± 3.14 | ||||||
| ANB (°) | ||||||
| Cases: 1.4 ± 2.9 Controls: 3.6 ± 1.98 | ||||||
| NMe (mm) | ||||||
| Cases: 97.7 ± 7.28 Controls: 108.3 ± 5.59 | ||||||
| SGo (mm) | ||||||
| Cases: 62.7 ± 5.9 Controls: 66.7 ± 4.71 | ||||||
| Suri et al.[ | 9 | Cases: 25 | Cases: 11–18 | Cases: Caucasian | Cases: 13 ♀ 12♂ | SN (mm) |
| Controls: 25 | Controls: 11–18 | Controls: Caucasian | Controls: 13 ♀ 12♂ | Cases: 64.97 ± 3.52 Controls: 75.17 ± 3.74 | ||
| SBa(mm) | ||||||
| Cases: 44.46 ± 3.05 Controls: 48.40 ± 3.01 | ||||||
| NBa (mm) | ||||||
| Cases: 103.08 ± 5.13 Controls: 112.48 ± 5.3 | ||||||
| SNBa (°) | ||||||
| Cases: 140.31 ± 3.75 Controls: 129.92 ± 4.06 | ||||||
| SNA (°) | ||||||
| Cases: 82.47 ± 4.34 Controls: 81.25 ± 2.87 | ||||||
| SNB (°) | ||||||
| Cases: 82.41 ± 4.36 Controls: 78.74 ± 2.64 | ||||||
| ANB (°) | ||||||
| Cases: 0.06 ± 2.51 Controls: 2.52 ± 1.48 | ||||||
| NMe (mm) | ||||||
| Cases: 106.23 ± 8.04 Controls: 121.74 ± 6 | ||||||
| SGo (mm) | ||||||
| Cases: 70.36 ± 8.88 Controls: 78.83 ± 6.45 | ||||||
| Korayem and Alkofide[ | 9 | Cases: 60 | Cases: 12–22 | Cases: Arab | Cases: 33 ♀ 27♂ | SN (mm) |
| Controls: 60 | Controls: 12–22 | Controls: Arab | Controls: 33 ♀ 27♂ | Cases: 65.20 ± 4.4 Controls: 72.90 ± 3.6 | ||
| SBa(mm) | ||||||
| Cases: 44.5 ± 3.3 Controls: 46.5 ± 3.3 | ||||||
| SNBa (°) | ||||||
| Cases: 138.53 ± 3.83 Controls:130.23 ± 1.96 | ||||||
| SNA (°) | ||||||
| Cases: 81.9 ± 2.4 Controls: 83.3 ± 2.5 | ||||||
| CoA (mm) | ||||||
| Cases: 85.7 ± 5.80 Controls: 92.7 ± 3 | ||||||
| SNB (°) | ||||||
| Cases: 81.4 ± 3 Controls: 80.4 ± 2.7 | ||||||
| ANB (°) | ||||||
| Cases: 0.54 ± 2.6 Controls: 3.1 ± 0.9 | ||||||
| Alió et al.[ | 9 | Cases: 47 | Cases: 8–18 | Cases: Caucasian | Cases: 22 ♀ 25♂ | SNA (°) |
| Controls: 38 | Controls: 8–18 | Controls: Caucasian | Controls: 16 ♀ 22♂ | Cases: 78.85 ± 3.44 Controls: 79.27 ± 3.18 | ||
| CoA (mm) | ||||||
| Cases: 78.89 ± 5.79 Controls: 88.57 ± 4.65 | ||||||
| Alonso Tosso and Naval[ | 8 | Cases: 33 | Cases: 5–19 | Cases: Caucasian | Cases: 15 ♀ 18♂ | SNBa (°) |
| Controls: 45 | Controls:5–19 | Controls: Caucasian | Controls: 22 ♀ 23♂ | Cases: 138.96 ± 4.13 Controls: 130.84 ± 5.56 |
Results of the pooled mean difference and heterogeneity statistics for each outcome.
| Outcome | MD+ | 95% CI | ||||||
|---|---|---|---|---|---|---|---|---|
| MDL | MDU | |||||||
| SN (mm) | 5 | − 8.036 | − 9.224 | − 6.848 | 8.24 | 4 | .083 | 51.5 |
| SBa (mm) | 4 | − 2.931 | − 4.048 | − 1.815 | 7.52 | 3 | .057 | 60.1 |
| NBa (mm) | 3 | − 8.336 | − 9.811 | − 6.860 | 1.92 | 2 | .383 | 0 |
| SNBa (°) | 5 | 8.518 | 7.391 | 9.646 | 7.95 | 4 | .093 | 49.7 |
| SNA (°) | 5 | − 0.841 | − 1.742 | 0.060 | 6.96 | 4 | .138 | 42.5 |
| CoA (mm) | 3 | − 8.546 | − 10.358 | − 6.734 | 4.71 | 2 | .095 | 57.5 |
| SNB (°) | 3 | 0.688 | − 2.286 | 3.661 | 20.30 | 2 | < .001 | 90.1 |
| ANB (°) | 4 | − 2.388 | − 2.903 | − 1.872 | 1.45 | 3 | .695 | 0 |
| NMe (mm) | 3 | − 12.052 | − 15.574 | − 8.530 | 4.51 | 2 | .105 | 55.7 |
| SGo (mm) | 3 | − 6.137 | − 8.965 | − 3.309 | 3.62 | 2 | .163 | 44.8 |
k, number of studies. MD+, pooled mean difference. MDL and MDU, lower and upper limits of the 95% confidence interval around MD+. Q, heterogeneity statistic. DF, degrees of freedom of the Q statistic. p, probability level of the Q statistic. I2, heterogeneity index.
Figure 3Forest plot for the outcome ‘SN (mm)’ as a function of the age group (1 = 6–11 years old), 2 = 5–22 years old).
Figure 4Forest plot for the outcome ‘SBa (mm)’ as a function of the age group (1 = 6–11 years old), 2 = 5–22 years old).
Figure 5Forest plot for the outcome ‘BaN (mm)’ as a function of the age group (1 = 6–11 years old), 2 = 5–22 years old).
Figure 6Forest plot for the outcome ‘SNBa (°)’ as a function of the age group (1 = 6–11 years old), 2 = 5–22 years old).
Figure 7Forest plot for the outcome ‘SNA (°)’ as a function of the age group (1 = 6–11 years old), 2 = 5–22 years old).
Figure 8Forest plot for the outcome ‘CoA (mm)’ as a function of the age group (1 = 6–11 years old), 2 = 5–22 years old).
Figure 9Forest plot for the outcome ‘SNB (°)’ as a function of the age group (1 = 6–11 years old), 2 = 5–22 years old).
Figure 10Forest plot for the outcome ‘ANB (°)’ as a function of the age group (1 = 6–11 years old), 2 = 5–22 years old).
Figure 11Forest plot for the outcome ‘NMe (mm)’ as a function of the age group (1 = 6–11 years old), 2 = 5–22 years old).
Figure 12Forest plot for the outcome ‘SGo (mm)’ as a function of the age group (1 = 6–11 years old), 2 = 5–22 years old).
Results of the subgroup analyses for the two categories of age ranges.
| Outcome | |||
|---|---|---|---|
| SN (mm) | 2.01 | 1 | .156 |
| SBa (mm) | 1.41 | 1 | .235 |
| NBa (mm) | 2.52 | 1 | .112 |
| SNBa (°) | 4.24 | 1 | .039 |
| SNA (°) | 1.07 | 1 | .301 |
| CoA (mm) | 0.45 | 1 | .504 |
| SNB (°) | 8.48 | 1 | .004 |
| ANB (°) | 0.93 | 1 | .335 |
| NMe (mm) | 4.43 | 1 | .035 |
| SGo (mm) | 1.47 | 1 | .225 |
QB, statistic for testing the statistical significance the difference between the mean effect sizes for the two age ranges. df, degrees of freedom of the QB statistic. p, probability level of the QB statistic.